Promoting Health through Vitamin D Therapeutics
Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism |
|
Recent News:
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
September 15, 2020
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
June 01, 2020
OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies
March 25, 2020 |